Pharma Industry News

Merck attempts to reduce levels of carcinogenic compounds in diabetes drugs

Written by David Miller

Pharmaceutical company Merck has announced that it is attempting to reduce levels of a cancer-causing compound which has been found in its popular type 2 diabetes drugs. The compound, known as nitrosamines or NTTP, often emerges from chemical reactions that can take place throughout the manufacturing process.

These compounds are naturally found in fresh fruits and vegetables, grilled meats and fish, and in water and the air.

read more

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]